TY  - JOUR
AU  - Dorst, Daphne N
AU  - Smeets, Esther M M
AU  - Klein, Christian
AU  - Frielink, Cathelijne
AU  - Geijs, Daan
AU  - Trajkovic-Arsic, Marija
AU  - Cheung, Phyllis F Y
AU  - Stommel, Martijn W J
AU  - Gotthardt, Martin
AU  - Siveke, Jens T
AU  - Aarntzen, Erik H J G
AU  - van Lith, Sanne A M
TI  - Fibroblast Activation Protein-Targeted Photodynamic Therapy of Cancer-Associated Fibroblasts in Murine Models for Pancreatic Ductal Adenocarcinoma.
JO  - Molecular pharmaceutics
VL  - 20
IS  - 8
SN  - 1543-8384
CY  - Washington, DC
PB  - American Chemical Society
M1  - DKFZ-2023-01498
SP  - 4319-4330
PY  - 2023
N1  - 2023 Aug 7;20(8):4319-4330
AB  - Patients with pancreatic ductal adenocarcinoma (PDAC) have a dismal 5 year survival of 9
KW  - cancer-associated fibroblast (CAF) (Other)
KW  - fibroblast activation protein (FAP) (Other)
KW  - pancreatic ductal adenocarcinoma (PDAC) (Other)
KW  - syngeneic models (Other)
KW  - targeted photodynamic therapy (tPDT) (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:37485886
DO  - DOI:10.1021/acs.molpharmaceut.3c00453
UR  - https://inrepo02.dkfz.de/record/277783
ER  -